3653 results for «445»

Filter By

3653 results

Clinical Cases on Peripheral Interventions - Part 2

17 May 2022 – From EuroPCR 2022

Watch these videos on peripheral interventions to discover various challenging cases: temporary extracorporeal shunting (TES) after infrarenal REBOA, miraculous mimic of percutaneous lung transplant, spontaneous femoral artery branch perforation, and more!

Clinical Cases on Peripheral Interventions

Transcatheter solutions in complex valvular or structural scenarios - Part 1

17 May 2022 – From EuroPCR 2022

Watch these videos dedicated to transcatheter solutions in complex valvular or structural scenarios to discover a selection of challenging cases: downward dislocation of a TAVI valve into the left ventricle, failed aortic valve after ROSS procedure, and much more!

Transcatheter solutions in complex valvular or structural scenarios - Part 1

Sirolimus coated balloon: expanding the scope of coronary artery disease treatment

07 Oct 2022 – From AICT-ASIAPCR 2022

Consult this session to understand the technology and scientific evidence of the novel sirolimus drug-coated balloon, to learn its utility for PCI in a variety of lesion and patient subsets and to understand the evidence and outcomes in real-world patients.

Sirolimus coated balloon: expanding the scope of coronary artery disease treatment

Treatment of small vessel disease - To stent or not to stent?

07 Oct 2022 – From AICT-AsiaPCR 2022

Consult this session if you want to learn the tips and tricks to perform a small vessel disease intervention and to discuss the pros and cons of treating small vessel disease with DCB and/or DES.

Treatment of small vessel disease - To stent or not to stent?

Elixir Medical To Announce Late-Breaking Clinical Data at EuroPCR 2023 Session Featuring World’s First Transforming Coronary Artery Implant Designed to Restore Vessel Physiology and Function

09 May 2023

EuroPCR 2025: Late-breaking data demonstrate sustained significantly lower event rates with Elixir Medical’s DynamX® Bioadaptor over drug-eluting stent through three Years

21 May 2025

EuroPCR 2026: Elixir Medical's DynamX® bioadaptor demonstrates significantly lower event rates than drug-eluting stent in long-term follow-up, including reduction in cardiovascular death

19 May 2026

Positive 3-year results from FIRE Trial demonstrate Supraflex Cruz’s safety and efficacy in elderly heart attack patients

26 Sep 2025

A randomised, multicenter, non-inferiority comparison of intravascular lithotripsy and super-high-pressure non-compliant balloons for treatment of calcified and refractory coronary lesions - The VICTORY trial

27 Oct 2025

Mirvat Alasnag provides her take on the VICTORY trial presented by Matthias Bossard at TCT 2025 in San Francisco.

Dr. Mirvat Alasnag

Author

Mirvat Alasnag
VICTORY: Intravascular lithotripsy vs. super-high-pressure PTCA in calcified and refractory coronary lesions

Promising Safety and Efficacy Results for Supraflex Cruz in HBR Subset Analysis from FIRE Trial, with 1-Month DAPT

03 Nov 2023

Elixir Medical’s DynamX Bioadaptor demonstrates significant improvement over contemporary drug-eluting stent in patients with acute coronary syndrome and complex lesion subsets after six months

28 Oct 2024

EuroPCR 2024: Late-breaking data demonstrate significant clinical advantage of Elixir Medical’s DynamX bioadaptor over standard-of-care drug-eluting stent at two years

14 May 2024

EuroPCR 2023: Late-Breaking Clinical Data Demonstrate Elixir Medical’s DynamX Bioadaptor Restores Vessel Motion and Function with Better Effectiveness at 12 Months Compared to a Leading Drug-Eluting Stent (DES)

17 May 2023

Didn’t find what you were looking for?